Stephen Kanes

6.2k total citations · 3 hit papers
85 papers, 4.6k citations indexed

About

Stephen Kanes is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephen Kanes has authored 85 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephen Kanes's work include Neuroscience and Neuropharmacology Research (18 papers), Maternal Mental Health During Pregnancy and Postpartum (16 papers) and Tryptophan and brain disorders (15 papers). Stephen Kanes is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Maternal Mental Health During Pregnancy and Postpartum (16 papers) and Tryptophan and brain disorders (15 papers). Stephen Kanes collaborates with scholars based in United States, United Kingdom and Sweden. Stephen Kanes's co-authors include Steven J. Siegel, Raquel E. Gur, Ruben C. Gur, Christian G. Kohler, Warren B. Bilker, Samantha Meltzer‐Brody, Jeffrey M. Jonas, Colleen Brensinger, Ted Abel and David R. Rubinow and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Psychiatry.

In The Last Decade

Stephen Kanes

84 papers receiving 4.5k citations

Hit Papers

Facial Emotion Recognition in Schizophrenia: Intensity Ef... 2003 2026 2010 2018 2003 2018 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Kanes United States 36 1.3k 1.2k 1.1k 849 686 85 4.6k
Igor Elman United States 40 1.4k 1.1× 1.8k 1.5× 1.7k 1.6× 527 0.6× 404 0.6× 141 5.7k
Takeshi Inoue Japan 41 813 0.6× 1.2k 1.0× 1.6k 1.5× 955 1.1× 249 0.4× 260 5.4k
Cornelius Schüle Germany 42 890 0.7× 600 0.5× 1.4k 1.3× 879 1.0× 285 0.4× 126 5.1k
Gabriella Juhász Hungary 38 1.3k 1.0× 792 0.7× 803 0.8× 558 0.7× 160 0.2× 163 4.1k
Julia Sacher Germany 32 546 0.4× 916 0.8× 547 0.5× 429 0.5× 638 0.9× 78 3.6k
Hiroaki Hori Japan 38 1.1k 0.8× 1.0k 0.9× 573 0.5× 667 0.8× 177 0.3× 157 5.0k
Thomas C. Baghai Germany 45 1.3k 1.0× 839 0.7× 1.7k 1.6× 1.3k 1.6× 256 0.4× 170 6.7k
Peter Zill Germany 39 1.0k 0.8× 647 0.6× 1.8k 1.7× 1.2k 1.4× 165 0.2× 131 5.1k
Jean‐Michel Aubry Switzerland 31 1.1k 0.8× 592 0.5× 1.3k 1.3× 388 0.5× 185 0.3× 72 4.1k
Miho Ota Japan 38 1.1k 0.8× 1.0k 0.9× 737 0.7× 1.2k 1.4× 185 0.3× 211 5.2k

Countries citing papers authored by Stephen Kanes

Since Specialization
Citations

This map shows the geographic impact of Stephen Kanes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Kanes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Kanes more than expected).

Fields of papers citing papers by Stephen Kanes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Kanes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Kanes. The network helps show where Stephen Kanes may publish in the future.

Co-authorship network of co-authors of Stephen Kanes

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Kanes. A scholar is included among the top collaborators of Stephen Kanes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Kanes. Stephen Kanes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deligiannidis, Kristina M., Leslie Citrome, Sarah Acaster, et al.. (2023). Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression. The Journal of Clinical Psychiatry. 84(1). 32 indexed citations
2.
Parikh, Sagar V., Scott T. Aaronson, Sanjay J. Mathew, et al.. (2023). Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study. Neuropsychopharmacology. 49(2). 467–475. 15 indexed citations
3.
Gerbasi, Margaret E., Mark Kosinski, Samantha Meltzer‐Brody, et al.. (2021). Achieving clinical response in postpartum depression leads to improvement in health-related quality of life. Current Medical Research and Opinion. 37(7). 1221–1231. 2 indexed citations
4.
Koenig, Aaron, Harald Murck, Yingchun Luo, et al.. (2020). Using a Multimodal Biomarker Approach to Identify Functional Target Engagement of the Novel NMDA Positive Allosteric Modulator SAGE-718 (1944). Neurology. 94(15_supplement). 1 indexed citations
5.
Nguyen, David P., Anne C. Smith, E. Hoffman, et al.. (2020). Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor (4499). Neurology. 94(15_supplement). 1 indexed citations
6.
Gerbasi, Margaret E., Samantha Meltzer‐Brody, Sarah Acaster, et al.. (2020). Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making. Journal of Women s Health. 30(3). 385–392. 13 indexed citations
7.
Meltzer‐Brody, Samantha, Helen Colquhoun, Robert Riesenberg, et al.. (2019). Brexanolone Injection in Postpartum Depression: Two Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trials. Obstetrical & Gynecological Survey. 74(4). 219–220. 1 indexed citations
8.
Meltzer‐Brody, Samantha, Helen Colquhoun, Robert Riesenberg, et al.. (2018). Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. The Lancet. 392(10152). 1058–1070. 407 indexed citations breakdown →
9.
Rosenthal, Eric S., Jan Claassen, Mark S. Wainwright, et al.. (2017). Brexanolone as adjunctive therapy in super‐refractory status epilepticus. Annals of Neurology. 82(3). 342–352. 78 indexed citations
10.
Kanes, Stephen, Eric S. Rosenthal, Henrikas Vaitkevicius, et al.. (2016). 547-SSE-201 for Super-Refractory Status Epilepticus: Response and Relationship to Underlying Patient Characteristics (S14.003). Neurology. 86(16_supplement). 3 indexed citations
11.
Norberg, Åke, et al.. (2015). A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia. Anesthesia & Analgesia. 121(4). 894–903. 10 indexed citations
12.
McCarthy, Dennis J., Robert Alexander, Mark A. Smith, et al.. (2012). Glutamate-based depression GBD. Medical Hypotheses. 78(5). 675–681. 37 indexed citations
13.
Kelly, Michy P., Joel M. Stein, Christopher G. Vecsey, et al.. (2008). Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Gαs, a G-protein subunit genetically linked to schizophrenia. Molecular Psychiatry. 14(4). 398–415. 52 indexed citations
14.
Kanes, Stephen, et al.. (2006). Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience. 144(1). 239–246. 137 indexed citations
15.
Siegel, Steven J., Christina R. Maxwell, Danielle Trief, et al.. (2005). Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience. 133(3). 729–738. 41 indexed citations
16.
Gur, Raquel E., Christian G. Kohler, Bruce I. Turetsky, et al.. (2004). A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biological Psychiatry. 55(5). 512–517. 94 indexed citations
17.
Maxwell, Christina R., Yuling Liang, Stephen Kanes, et al.. (2004). Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse N1 Auditory Evoked Potential. Neuropsychopharmacology. 29(4). 739–746. 52 indexed citations
18.
Connolly, Patrick, Christina R. Maxwell, Yuling Liang, et al.. (2004). The Effects of Ketamine Vary Among Inbred Mouse Strains and Mimic Schizophrenia for the P80, but not P20 or N40 Auditory ERP Components. Neurochemical Research. 29(6). 1179–1188. 76 indexed citations
19.
Kanes, Stephen, Katherine M. Dains, Laura Cipp, et al.. (1996). Mapping the genes for haloperidol-induced catalepsy.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 1016–1025. 37 indexed citations
20.
Hitzemann, Robert, et al.. (1995). Genetics and the Organization of the Basal Ganglia. International review of neurobiology. 38. 43–94. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026